Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for technology industry professionals · Thursday, October 17, 2024 · 752,739,561 Articles · 3+ Million Readers

Contacts in the Center for Biologics Evaluation & Research (CBER)

 Write to:

Food and Drug Administration
Center for Biologics Evaluation and Research (CBER)
10903 New Hampshire Avenue
Silver Spring, MD 20993-0002

Email:

Consumers:
ocod@fda.hhs.gov

Manufacturers Assistance:
Industry.Biologics@fda.hhs.gov
Manufacturers include blood, plasma and tissue banks, clinical investigators and other members of regulated industry who are developing pharmaceuticals derived from blood and blood components, vaccines, or cellular and gene therapies.


Table of Contents


Report an emergency

back to top


Emergency IND requests

INDs are unapproved products that need to be requested by a physician or health care provider.

back to top


Report a problem with FDA-regulated products

 

back to top


Stay informed

back to top


Press Inquiries

back to top


Freedom of Information Act requests

back to top


Find a FDA staff member

back to top


Comment on proposed regulations

back to top


Resolve a dispute or Request Product Jurisdiction

back to top


Report a problem with this website

Send email to cberwebmaster@fda.hhs.gov. Indicate the web address (URL) where you encountered the problem and the type of issue (such as a broken link, problem downloading a document, etc.).

back to top


Requesting speakers

Please direct all inquiries to cberspeakerliaison@fda.hhs.gov

Follow these procedures to request speakers for your event.

back to top


Industry contacts

Visit Industry (Biologics) for more information.

back to top

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release